sales@ambeed.com

Structure Search

List Search MOL Search Structure Search

Hello, Sign in

Home Cart 0 Sign in

X

[ CAS No. 214759-66-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}

Cat. No.: {[proInfo.prAm]}

DV 2D 3D

3d Animation Molecule Structure of 214759-66-7

Chemical Structure| 214759-66-7

Chemical Structure| 214759-66-7

Structure of 214759-66-7 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

For Research Only 120K+ Compounds Competitive Price 1-2 Day Shipping

Quality Control of [ 214759-66-7 ]

COA NMR CNMR HPLC LC-MS

Related Doc. of [ 214759-66-7 ]

SDS Specification

Alternatived Products of [ 214759-66-7 ]

Product Citations

Product Details of [ 214759-66-7 ]

CAS No. :	214759-66-7	MDL No. :	MFCD12756074
Formula :	C₉H₆ClNO₂	Boiling Point :	-
Linear Structure Formula :	-	InChI Key :	KDNFJYKKFLHZKZ-UHFFFAOYSA-N
M.W :	195.60	Pubchem ID :	19076698
Synonyms :

Calculated chemistry of [ 214759-66-7 ] Expand+

Physicochemical Properties

Num. heavy atoms :	13
Num. arom. heavy atoms :	6
Fraction Csp3 :	0.11
Num. rotatable bonds :	2
Num. H-bond acceptors :	3.0
Num. H-bond donors :	0.0
Molar Refractivity :	47.45
TPSA :	50.09 Å²

Pharmacokinetics

GI absorption :	High
BBB permeant :	Yes
P-gp substrate :	No
CYP1A2 inhibitor :	Yes
CYP2C19 inhibitor :	No
CYP2C9 inhibitor :	No
CYP2D6 inhibitor :	No
CYP3A4 inhibitor :	No
Log Kp (skin permeation) :	-5.99 cm/s

Lipophilicity

Log Po/w (iLOGP) :	2.01
Log Po/w (XLOGP3) :	2.12
Log Po/w (WLOGP) :	2.0
Log Po/w (MLOGP) :	1.86
Log Po/w (SILICOS-IT) :	2.33
Consensus Log Po/w :	2.06

Druglikeness

Lipinski :	0.0
Ghose :	None
Veber :	0.0
Egan :	0.0
Muegge :	1.0
Bioavailability Score :	0.55

Water Solubility

Log S (ESOL) :	-2.6
Solubility :	0.494 mg/ml ; 0.00252 mol/l
Class :	Soluble
Log S (Ali) :	-2.8
Solubility :	0.308 mg/ml ; 0.00157 mol/l
Class :	Soluble
Log S (SILICOS-IT) :	-3.18
Solubility :	0.129 mg/ml ; 0.000661 mol/l
Class :	Soluble

Medicinal Chemistry

PAINS :	0.0 alert
Brenk :	0.0 alert
Leadlikeness :	1.0
Synthetic accessibility :	1.81

Safety of [ 214759-66-7 ]

Signal Word:	Warning	Class:	N/A
Precautionary Statements:	P261-P280-P305+P351+P338	UN#:	N/A
Hazard Statements:	H302-H315-H319-H332-H335	Packing Group:	N/A
GHS Pictogram:

Application In Synthesis of [ 214759-66-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

Upstream synthesis route of [ 214759-66-7 ]
Downstream synthetic route of [ 214759-66-7 ]

[ 214759-66-7 ] Synthesis Path-Upstream 1~2

1
[ 84228-44-4 ]
[ 214759-66-7 ]

Yield	Reaction Conditions	Operation in experiment
68%	Stage #1: With tert.-butylnitrite; boron trifluoride diethyl etherate In diethyl ether; dichloromethane at -20 - 20℃; for 72.5 h; Stage #2: at 0 - 20℃; for 18.5 h; Stage #3: With iron(III) chloride In water at 20℃; for 0.5 h;	A solution of methyl 4-amino-3-chlorobenzoate (5.0 g, 27 mmol) was stirred at -20°C in DCM (20 mL) and treated sequentially with a solution of BF3.0Et.2 (5.5 mL, 43 mmol) in anhydrous diethyl ether (10 mL) and ferf-butyl nitrite (6.0 mL, 46 mmol). The reaction mixture was stirred at -20°C for 30 min and then allowed to warm slowly to RT and stirred for 72 h. The reaction mixture was filtered and the precipitate was washed sequentially with DCM (50 mL), Et.20 (50 mL) and isohexane (50 mL) to afford the intermediate diazonium salt. The salt was dissolved in H2O (200 mL) and slowly added to a stirred mixture of potassium cyanide (1.98 g, 30.4 mmol) and copper (I) cyanide (2.73 g, (0572) 30.4 mmol) in H₂0 (300 mL) at 0-5°C. After the addition the mixture was stirred at 0-5°C for 0.5 h, then at RT for 18 h. The mixture was treated with 10percent aqueous FeC solution (200 mL) and stirred at RT for 30 min. The product was extracted with EtOAc (3 x 200 mL) and the combined organic extracts were washed with brine (400 mL), dried over MgSC , filtered and concentrated in vacuo. The product was purified by silica gel chromatography (120 g, 0-10percent EtOAc in isohexane) to afford the title compound (2) (3.56 g, 68percent) as an orange solid: m/z 196 [M+H]⁺ (ES⁺); ¹ H NMR (400 MHz, DMSO-d₆) δ: 8.17 - 8.14 (2H, m), 8.04 (1 H, dd), 3.91 (3H, s)

Reference： [1] Patent: WO2016/97004, 2016, A1, . Location in patent: Page/Page column 67; 68

2
[ 117738-74-6 ]
[ 214759-66-7 ]

Yield	Reaction Conditions	Operation in experiment
43.7%	With tetrakis(triphenylphosphine) palladium⁽⁰⁾ In N,N-dimethyl-formamide at 100℃;	(Step 3) (0896) A mixture of methyl 4-bromo-3-chlorobenzoate (5.84 g, 23.41 mmol), tetrakis(triphenylphosphine)palladium (1.352 g, 1.17 mmol), copper(I) cyanide (1.484 mL, 23.41 mmol) and DMF (50 mL) was stirred at 100°C overnight. The reaction mixture was allowed to be cooled to room temperature, saturated brine was added thereto, and the mixture was extracted with ethyl acetate. The organic layer was washed with saturated brine, and dried over magnesium sulfate, and the solvent was evaporated under reduced pressure. The obtained residue was purified by silica gel column chromatography (solvent gradient; 5→50percent ethyl acetate/hexane) to give methyl 3-chloro-4-cyanobenzoate (2.0 g, 10.22 mmol, 43.7percent) as a colorless solid. ¹H-NMR(300MHz,CDCl₃):δ4.01(3H,s),7.92(1H,d,J=8.7Hz),8.38(1H,dd,J=8 .1,1.7Hz),8.46(1H,d,J=1.5Hz).

Reference： [1] Patent: EP2975031, 2016, A1, . Location in patent: Paragraph 0896

[ 214759-66-7 ] Synthesis Path-Downstream 1~47

1
[ 16419-60-6 ]
[ 214759-66-7 ]
[ 565451-70-9 ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2003,vol. 13,p. 1367 - 1371

2
[ 13922-41-3 ]
[ 214759-66-7 ]
4-cyano-3-naphthalen-1-yl-benzoic acid methyl ester [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2003,vol. 13,p. 1367 - 1371

3
[ 63503-60-6 ]
[ 214759-66-7 ]
[ 641621-26-3 ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2003,vol. 13,p. 4001 - 4005

4
[ 1679-18-1 ]
[ 214759-66-7 ]
4'-chloro-6-cyano-biphenyl-3-carboxylic acid methyl ester [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2003,vol. 13,p. 4001 - 4005

5
[ 3900-89-8 ]
[ 214759-66-7 ]
2'-chloro-6-cyano-biphenyl-3-carboxylic acid methyl ester [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2003,vol. 13,p. 4001 - 4005

6
[ 214759-66-7 ]
[ 717832-79-6 ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2003,vol. 13,p. 4001 - 4005

7
[ 214759-66-7 ]
[ 641621-27-4 ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2003,vol. 13,p. 4001 - 4005

8
[ 214759-66-7 ]
[ 717832-80-9 ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2003,vol. 13,p. 4001 - 4005

9
[ 214759-66-7 ]
[ 717123-97-2 ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2003,vol. 13,p. 4001 - 4005

10
[ 214759-66-7 ]
4'-chloro-5-hydroxymethyl-biphenyl-2-carbonitrile [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2003,vol. 13,p. 4001 - 4005

11
[ 214759-66-7 ]
2'-chloro-5-hydroxymethyl-biphenyl-2-carbonitrile [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2003,vol. 13,p. 4001 - 4005

12
[ 214759-66-7 ]
3'-chloro-5-[hydroxy-(3-methyl-3<i>H</i>-imidazol-4-yl)-methyl]-biphenyl-2-carbonitrile [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2003,vol. 13,p. 4001 - 4005

13
[ 214759-66-7 ]
4'-chloro-5-[hydroxy-(3-methyl-3<i>H</i>-imidazol-4-yl)-methyl]-biphenyl-2-carbonitrile [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2003,vol. 13,p. 4001 - 4005

14
[ 214759-66-7 ]
2'-chloro-5-[hydroxy-(3-methyl-3<i>H</i>-imidazol-4-yl)-methyl]-biphenyl-2-carbonitrile [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2003,vol. 13,p. 4001 - 4005

15
[ 214759-66-7 ]
6-[(3'-chloro-6-cyano-biphenyl-3-yl)-(3-methyl-3<i>H</i>-imidazol-4-yl)-methoxymethyl]-5-(3-chloro-phenyl)-1-methyl-2-oxo-1,2-dihydro-pyridine-3-carbonitrile [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2003,vol. 13,p. 4001 - 4005

16
[ 214759-66-7 ]
6-[(3'-chloro-6-cyano-biphenyl-3-yl)-(3-methyl-3<i>H</i>-imidazol-4-yl)-methoxymethyl]-5-(3,5-dichloro-phenyl)-1-methyl-2-oxo-1,2-dihydro-pyridine-3-carbonitrile [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2003,vol. 13,p. 4001 - 4005

17
[ 214759-66-7 ]
6-[(2'-chloro-6-cyano-biphenyl-3-yl)-(3-methyl-3<i>H</i>-imidazol-4-yl)-methoxymethyl]-1-methyl-2-oxo-5-(4-trifluoromethoxy-phenyl)-1,2-dihydro-pyridine-3-carbonitrile [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2003,vol. 13,p. 4001 - 4005

18
[ 214759-66-7 ]
6-[(3'-chloro-6-cyano-biphenyl-3-yl)-(3-methyl-3<i>H</i>-imidazol-4-yl)-methoxymethyl]-1-methyl-2-oxo-5-(4-trifluoromethoxy-phenyl)-1,2-dihydro-pyridine-3-carbonitrile [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2003,vol. 13,p. 4001 - 4005

19
[ 214759-66-7 ]
6-[(4'-chloro-6-cyano-biphenyl-3-yl)-(3-methyl-3<i>H</i>-imidazol-4-yl)-methoxymethyl]-1-methyl-2-oxo-5-(4-trifluoromethoxy-phenyl)-1,2-dihydro-pyridine-3-carbonitrile [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2003,vol. 13,p. 4001 - 4005

20
[ 214759-66-7 ]
[ 371766-26-6 ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2003,vol. 13,p. 1367 - 1371

21
[ 214759-66-7 ]
[ 398457-02-8 ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2003,vol. 13,p. 1367 - 1371

22
[ 214759-66-7 ]
[ 371766-01-7 ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2003,vol. 13,p. 1367 - 1371

23
[ 214759-66-7 ]
[ 371765-74-1 ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2003,vol. 13,p. 1367 - 1371

24
[ 214759-66-7 ]
(6-cyano-2'-methyl-biphenyl-3-yl)-carbamic acid <i>tert</i>-butyl ester [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2003,vol. 13,p. 1367 - 1371

25
[ 214759-66-7 ]
[ 371763-57-4 ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2003,vol. 13,p. 1367 - 1371

26
[ 214759-66-7 ]
(4-cyano-3-naphthalen-1-yl-phenyl)-carbamic acid <i>tert</i>-butyl ester [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2003,vol. 13,p. 1367 - 1371

27
[ 214759-66-7 ]
4-(methyl((1-methyl-1H-imidazol-5-yl)methyl)amino)-2-(1-naphthyl)benzonitrile [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2003,vol. 13,p. 1367 - 1371

28
[ 214759-66-7 ]
5-(benzyl((1-methyl-1H-imidazol-5-yl)methyl)amino)-2'-methyl(1,1'-biphenyl)-2-carbonitrile [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2003,vol. 13,p. 1367 - 1371

29
[ 214759-66-7 ]
5-(benzyl(1H-imidazol-5-ylmethyl)amino)-2'-methyl(1,1'-biphenyl)-2-carbonitrile [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2003,vol. 13,p. 1367 - 1371

30
[ 214759-66-7 ]
4-(benzyl((1-methyl-1H-imidazol-5-yl)methyl)amino)-2-(1-naphthyl)benzonitrile [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2003,vol. 13,p. 1367 - 1371

31
[ 214759-66-7 ]
5-((3-cyanobenzyl)((1-methyl-1H-imidazol-5-yl)methyl)amino)-2'-methyl(1,1'-biphenyl)-2-carbonitrile [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2003,vol. 13,p. 1367 - 1371

32
[ 214759-66-7 ]
5-((4-cyanobenzyl)((1-methyl-1H-imidazol-5-yl)methyl)amino)-2'-methyl(1,1'-biphenyl)-2-carbonitrile [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2003,vol. 13,p. 1367 - 1371

33
[ 214759-66-7 ]
N-(4-cyano-3-(1-naphthyl)phenyl)-N-((1-methyl-1H-imidazol-5-yl)methyl)-benzamide [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2003,vol. 13,p. 1367 - 1371

34
[ 214759-66-7 ]
4-(hexyl((1-methyl-1H-imidazol-5-yl)methyl)amino)-2-(1-naphthyl)benzonitrile [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2003,vol. 13,p. 1367 - 1371

35
[ 214759-66-7 ]
4-((3-chlorobenzyl)((1-methyl-1H-imidazol-5-yl)methyl)amino)-2-(1-naphthyl)-benzonitrile [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2003,vol. 13,p. 1367 - 1371

36
[ 214759-66-7 ]
N-(4-cyano-3-(1-naphthyl)phenyl)-N-((1-methyl-1H-imidazol-5-yl)methyl)benzene-sulfonamide [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2003,vol. 13,p. 1367 - 1371

37
[ 214759-66-7 ]
4-((4-cyanobenzyl)((1-methyl-1H-imidazol-5-yl)methyl)amino)-2-(1-naphthyl)-benzonitrile [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2003,vol. 13,p. 1367 - 1371

38
[ 214759-66-7 ]
4-((3-cyanobenzyl)((1-methyl-1H-imidazol-5-yl)methyl)amino)-2-(1-naphthyl)-benzonitrile [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2003,vol. 13,p. 1367 - 1371

39
[ 214759-66-7 ]
4-[(4-cyano-3-naphthalen-1-yl-phenyl)-(3-methyl-3<i>H</i>-imidazol-4-ylmethyl)-amino]-methyl}-pyridine-2-carbonitrile [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2003,vol. 13,p. 1367 - 1371

40
[ 214759-66-7 ]
[ 565451-82-3 ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2003,vol. 13,p. 1367 - 1371

41
[ 214759-66-7 ]
[ 371766-31-3 ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2003,vol. 13,p. 1367 - 1371

42
2-chloro-4-iodobenzonitrile [ No CAS ]
[ 214759-66-7 ]

Yield	Reaction Conditions	Operation in experiment
		EXAMPLE 54B methyl 3-chloro-4-cyanobenzoate The desired product was prepared by substituting Example 54A for 4-bromo-2-fluorobenzonitrile in Example 52A.
	With triethylamine; In methanol; dichloromethane;	EXAMPLE 35B methyl 3-chloro-4-cyanobenzoate A solution of Example 35A (39.9 g, 0.15 mol) in methanol (1 L) was treated with (1,1'-bis(diphenylphosphino)ferrocene)dichloropalladium(II) complex with dichloromethane (1:1) (1.25 g, 1.53 mmol) and triethylamine (24 mL), heated to 97 C. under 500 psi CO pressure for 20 hours, cooled to room temperature, filtered, and concentrated to provide the desired product of sufficient purity for subsequent use without further purification. 1H NMR (300 MHz, CDCl3) delta 8.17 (d, 1H), 8.02 (dd, 1H), 7.77 (d, 1H), 3.97 (s, 3H).

Reference： [1]Patent: US2002/115640,2002,A1
[2]Patent: US2002/19527,2002,A1

43
[ 117738-74-6 ]
copper(l) cyanide [ No CAS ]
[ 214759-66-7 ]

Yield	Reaction Conditions	Operation in experiment
43.7%	With tetrakis(triphenylphosphine) palladium(0); In N,N-dimethyl-formamide; at 100℃;	(Step 3) (0896) A mixture of methyl 4-bromo-3-chlorobenzoate (5.84 g, 23.41 mmol), tetrakis(triphenylphosphine)palladium (1.352 g, 1.17 mmol), copper(I) cyanide (1.484 mL, 23.41 mmol) and DMF (50 mL) was stirred at 100C overnight. The reaction mixture was allowed to be cooled to room temperature, saturated brine was added thereto, and the mixture was extracted with ethyl acetate. The organic layer was washed with saturated brine, and dried over magnesium sulfate, and the solvent was evaporated under reduced pressure. The obtained residue was purified by silica gel column chromatography (solvent gradient; 5?50% ethyl acetate/hexane) to give methyl 3-chloro-4-cyanobenzoate (2.0 g, 10.22 mmol, 43.7%) as a colorless solid. 1H-NMR(300MHz,CDCl3):delta4.01(3H,s),7.92(1H,d,J=8.7Hz),8.38(1H,dd,J=8 .1,1.7Hz),8.46(1H,d,J=1.5Hz).

Reference： [1]Patent: EP2975031,2016,A1 .Location in patent: Paragraph 0896

44
[ 214759-66-7 ]
3-chloro-4-cyanobenzoic acid [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
100%	With water; lithium hydroxide; In tetrahydrofuran; at 10 - 35℃; for 3h;	(Step 4) (0897) A mixture of the compound obtained in Step 3 (500 mg, 2.56 mmol), 4 mol/L aqueous lithium hydroxide solution (10 mL, 40.00 mmol) and THF (10 mL) was stirred at room temperature for 3 hr. The reaction mixture was washed with toluene, acidified with 1N hydrochloric acid, and extracted with ethyl acetate. The organic layer was washed with saturated brine, and dried over magnesium sulfate, and the solvent was evaporated under reduced pressure to give 3-chloro-4-cyanobenzoic acid as a colorless solid (quantitative). MS (API) :180 (M-H)

Reference： [1]Patent: EP2975031,2016,A1 .Location in patent: Paragraph 0897

45
[ 214759-66-7 ]
3-chloro-4-cyano-N-(4-((1,3-diethyl-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-6-yl)amino)-2-isopropyl-4-oxobutyl)benzamide [ No CAS ]

Reference： [1]Patent: EP2975031,2016,A1

46
potassium cyanide [ No CAS ]
copper(l) cyanide [ No CAS ]
[ 84228-44-4 ]
[ 214759-66-7 ]

Yield	Reaction Conditions	Operation in experiment
68%		A solution of <strong>[84228-44-4]methyl 4-amino-3-chlorobenzoate</strong> (5.0 g, 27 mmol) was stirred at -20C in DCM (20 mL) and treated sequentially with a solution of BF3.0Et.2 (5.5 mL, 43 mmol) in anhydrous diethyl ether (10 mL) and ferf-butyl nitrite (6.0 mL, 46 mmol). The reaction mixture was stirred at -20C for 30 min and then allowed to warm slowly to RT and stirred for 72 h. The reaction mixture was filtered and the precipitate was washed sequentially with DCM (50 mL), Et.20 (50 mL) and isohexane (50 mL) to afford the intermediate diazonium salt. The salt was dissolved in H2O (200 mL) and slowly added to a stirred mixture of potassium cyanide (1.98 g, 30.4 mmol) and copper (I) cyanide (2.73 g, (0572) 30.4 mmol) in H20 (300 mL) at 0-5C. After the addition the mixture was stirred at 0-5C for 0.5 h, then at RT for 18 h. The mixture was treated with 10% aqueous FeC solution (200 mL) and stirred at RT for 30 min. The product was extracted with EtOAc (3 x 200 mL) and the combined organic extracts were washed with brine (400 mL), dried over MgSC , filtered and concentrated in vacuo. The product was purified by silica gel chromatography (120 g, 0-10% EtOAc in isohexane) to afford the title compound (2) (3.56 g, 68%) as an orange solid: m/z 196 [M+H]+ (ES+); 1 H NMR (400 MHz, DMSO-d6) delta: 8.17 - 8.14 (2H, m), 8.04 (1 H, dd), 3.91 (3H, s)

Reference： [1]Patent: WO2016/97004,2016,A1 .Location in patent: Page/Page column 67; 68

47
[ 214759-66-7 ]
methyl 3-chloro-4-(N’-hydroxycarbamimidoyl)benzoate [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
72%	With hydroxylamine; In methanol; water; for 0.75h;Reflux;	A mixture of <strong>[214759-66-7]methyl 3-chloro-4-cyanobenzoate</strong> (2) (2.0 g, 10 mmol) and 50% (0576) aq. hydroxylamine solution (1 .25 mL, 20.4 mmol) in MeOH (30 mL) was stirred at reflux for 45 min. The reaction mixture was allowed to cool to RT, then diluted with H2O (50 mL) and extracted with EtOAc (150 mL). The organic solution was washed with brine (0577) (100 mL), dried over MgS04 and concentrated in vacuo to give methyl S-chloro^-^- hydroxycarbamimidoyl)benzoate (3) (1.9 g, 72%) as a yellow solid: m/z 229 [M+H]+ (ES+); 1H NMR (400 MHz, DMSO-d6) delta: 9.63 (1 H, s), 7.96 (1 H, d), 7.94 - 7.88 (1 H, m), 7.58 (1 H, d), 5.94 (2H, s), 3.89 (3H, s)

Reference： [1]Patent: WO2016/97004,2016,A1 .Location in patent: Page/Page column 67; 68

Recommend Products

Same Skeleton Products

Related Products

Isomers

Technical Information

• Acid-Catalyzed α -Halogenation of Ketones • Acyl Group Substitution • Add Hydrogen Cyanide to Aldehydes and Ketones to Produce Alcohols • Addition of a Hydrogen Halide to an Internal Alkyne • Alcohols Convert Acyl Chlorides into Esters • Alcohols from Haloalkanes by Acetate Substitution-Hydrolysis • Alcoholysis of Anhydrides • Alkyl Halide Occurrence • Alkylation of an Alkynyl Anion • Amine Synthesis from Nitriles • Amine Synthesis from Nitriles • Amines Convert Esters into Amides • An Alkane are Prepared from an Haloalkane • Benzylic Oxidation • Birch Reduction • Birch Reduction of Benzene • Blaise Reaction • Blanc Chloromethylation • Bouveault-Blanc Reduction • Catalytic Hydrogenation • Chloroalkane Synthesis with SOCI2 • Claisen Condensations Produce β-Dicarbonyl Compounds • Claisen Condensations Produce β-Dicarbonyl Compounds • Complete Benzylic Oxidations of Alkyl Chains • Complete Benzylic Oxidations of Alkyl Chains • Complex Metal Hydride Reductions • Conversion of Amino with Nitro • Convert Esters into Aldehydes Using a Milder Reducing Agent • Convert Haloalkanes into Alcohols by SN2 • Cyanohydrins can be Convert to Carbonyl Compounds under Basic Conditions • Decarboxylation of 3-Ketoacids Yields Ketones • Deprotection of Cbz-Amino Acids • Deprotonation of Methylbenzene • DIBAL Attack Nitriles to Give Ketones • Directing Electron-Donating Effects of Alkyl • Electrophilic Chloromethylation of Polystyrene • Ester Cleavage • Ester Hydrolysis • Friedel-Crafts Alkylation of Benzene with Acyl Chlorides • Friedel-Crafts Alkylation of Benzene with Carboxylic Anhydrides • Friedel-Crafts Alkylation of Benzene with Haloalkanes • Friedel-Crafts Alkylation Using Alkenes • Friedel-Crafts Alkylations of Benzene Using Alkenes • Friedel-Crafts Alkylations Using Alcohols • Friedel-Crafts Reaction • General Reactivity • Grignard Reaction • Grignard Reagents Transform Esters into Alcohols • Groups that Withdraw Electrons Inductively Are Deactivating and Meta Directing • Halogenation of Alkenes • Halogenation of Benzene • Hantzsch Pyridine Synthesis • Hiyama Cross-Coupling Reaction • Hydride Reductions • Hydrogenation to Cyclohexane • Hydrogenolysis of Benzyl Ether • Ketone Synthesis from Nitriles • Ketones Undergo Mixed Claisen Reactions to Form β-Dicarbonyl Compounds • Kinetics of Alkyl Halides • Kumada Cross-Coupling Reaction • Methylation of Ammonia • Nitration of Benzene • Nitriles Hydrolyze to Carboxylic Acids • Nucleophilic Aromatic Substitution • Nucleophilic Aromatic Substitution with Amine • Oxidation of Alkyl-substituted Benzenes Gives Aromatic Ketones • Preparation of Aldehydes and Ketones • Preparation of Alkylbenzene • Preparation of Amines • Reactions of Alkyl Halides with Reducing Metals • Reactions of Amines • Reactions of Benzene and Substituted Benzenes • Reactions with Organometallic Reagents • Reduction of an Ester to an Alcohol • Reduction of an Ester to an Aldehyde • Reductive Removal of a Diazonium Group • Reverse Sulfonation——Hydrolysis • Ritter Reaction • Specialized Acylation Reagents-Carbodiimides and Related Reagents • Stille Coupling • Substitution and Elimination Reactions of Alkyl Halides • Sulfonation of Benzene • Suzuki Coupling • The Acylium Ion Attack Benzene to Form Phenyl Ketones • The Claisen Rearrangement • The Cycloaddition of Dienes to Alkenes Gives Cyclohexenes • The Nitro Group Conver to the Amino Function • Thorpe-Ziegler Reaction • Transesterification • Vilsmeier-Haack Reaction

Historical Records

Related Functional Groups of
[ 214759-66-7 ]

Aryls

[ 58331-97-8 ]

Methyl 4-chloro-2-cyanobenzoate

Similarity: 0.95

[ 439117-38-1 ]

Methyl 5-chloro-2-cyanobenzoate

Similarity: 0.90

[ 98592-34-8 ]

Methyl 2-chloro-4-cyanobenzoate

Similarity: 0.88

[ 409127-32-8 ]

Methyl 2,6-dichloro-4-cyanobenzoate

Similarity: 0.85

[ 1261499-34-6 ]

2-Chloro-3-cyanobenzoic acid

Similarity: 0.84

Chlorides

[ 58331-97-8 ]

Methyl 4-chloro-2-cyanobenzoate

Similarity: 0.95

[ 439117-38-1 ]

Methyl 5-chloro-2-cyanobenzoate

Similarity: 0.90

[ 98592-34-8 ]

Methyl 2-chloro-4-cyanobenzoate

Similarity: 0.88

[ 409127-32-8 ]

Methyl 2,6-dichloro-4-cyanobenzoate

Similarity: 0.85

[ 1261499-34-6 ]

2-Chloro-3-cyanobenzoic acid

Similarity: 0.84

Esters

[ 58331-97-8 ]

Methyl 4-chloro-2-cyanobenzoate

Similarity: 0.95

[ 439117-38-1 ]

Methyl 5-chloro-2-cyanobenzoate

Similarity: 0.90

[ 98592-34-8 ]

Methyl 2-chloro-4-cyanobenzoate

Similarity: 0.88

[ 409127-32-8 ]

Methyl 2,6-dichloro-4-cyanobenzoate

Similarity: 0.85

[ 1126-46-1 ]

Methyl 4-chlorobenzoate

Similarity: 0.83

Nitriles

[ 58331-97-8 ]

Methyl 4-chloro-2-cyanobenzoate

Similarity: 0.95

[ 439117-38-1 ]

Methyl 5-chloro-2-cyanobenzoate

Similarity: 0.90

[ 98592-34-8 ]

Methyl 2-chloro-4-cyanobenzoate

Similarity: 0.88

[ 409127-32-8 ]

Methyl 2,6-dichloro-4-cyanobenzoate

Similarity: 0.85

[ 1261499-34-6 ]

2-Chloro-3-cyanobenzoic acid

Similarity: 0.84

Ghs Precautionary Statements

Precautionary Statements-General
Code	Phrase
P101	If medical advice is needed,have product container or label at hand.
P102	Keep out of reach of children.
P103	Read label before use
Prevention
Code	Phrase
P201	Obtain special instructions before use.
P202	Do not handle until all safety precautions have been read and understood.
P210	Keep away from heat/sparks/open flames/hot surfaces. - No smoking.
P211	Do not spray on an open flame or other ignition source.
P220	Keep/Store away from clothing/combustible materials.
P221	Take any precaution to avoid mixing with combustibles
P222	Do not allow contact with air.
P223	Keep away from any possible contact with water, because of violent reaction and possible flash fire.
P230	Keep wetted
P231	Handle under inert gas.
P232	Protect from moisture.
P233	Keep container tightly closed.
P234	Keep only in original container.
P235	Keep cool
P240	Ground/bond container and receiving equipment.
P241	Use explosion-proof electrical/ventilating/lighting/equipment.
P242	Use only non-sparking tools.
P243	Take precautionary measures against static discharge.
P244	Keep reduction valves free from grease and oil.
P250	Do not subject to grinding/shock/friction.
P251	Pressurized container: Do not pierce or burn, even after use.
P260	Do not breathe dust/fume/gas/mist/vapours/spray.
P261	Avoid breathing dust/fume/gas/mist/vapours/spray.
P262	Do not get in eyes, on skin, or on clothing.
P263	Avoid contact during pregnancy/while nursing.
P264	Wash hands thoroughly after handling.
P265	Wash skin thouroughly after handling.
P270	Do not eat, drink or smoke when using this product.
P271	Use only outdoors or in a well-ventilated area.
P272	Contaminated work clothing should not be allowed out of the workplace.
P273	Avoid release to the environment.
P280	Wear protective gloves/protective clothing/eye protection/face protection.
P281	Use personal protective equipment as required.
P282	Wear cold insulating gloves/face shield/eye protection.
P283	Wear fire/flame resistant/retardant clothing.
P284	Wear respiratory protection.
P285	In case of inadequate ventilation wear respiratory protection.
P231 + P232	Handle under inert gas. Protect from moisture.
P235 + P410	Keep cool. Protect from sunlight.
Response
Code	Phrase
P301	IF SWALLOWED:
P304	IF INHALED:
P305	IF IN EYES:
P306	IF ON CLOTHING:
P307	IF exposed:
P308	IF exposed or concerned:
P309	IF exposed or if you feel unwell:
P310	Immediately call a POISON CENTER or doctor/physician.
P311	Call a POISON CENTER or doctor/physician.
P312	Call a POISON CENTER or doctor/physician if you feel unwell.
P313	Get medical advice/attention.
P314	Get medical advice/attention if you feel unwell.
P315	Get immediate medical advice/attention.
P320
P302 + P352	IF ON SKIN: wash with plenty of soap and water.
P321
P322
P330	Rinse mouth.
P331	Do NOT induce vomiting.
P332	IF SKIN irritation occurs:
P333	If skin irritation or rash occurs:
P334	Immerse in cool water/wrap n wet bandages.
P335	Brush off loose particles from skin.
P336	Thaw frosted parts with lukewarm water. Do not rub affected area.
P337	If eye irritation persists:
P338	Remove contact lenses, if present and easy to do. Continue rinsing.
P340	Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P341	If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P342	If experiencing respiratory symptoms:
P350	Gently wash with plenty of soap and water.
P351	Rinse cautiously with water for several minutes.
P352	Wash with plenty of soap and water.
P353	Rinse skin with water/shower.
P360	Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
P361	Remove/Take off immediately all contaminated clothing.
P362	Take off contaminated clothing and wash before reuse.
P363	Wash contaminated clothing before reuse.
P370	In case of fire:
P371	In case of major fire and large quantities:
P372	Explosion risk in case of fire.
P373	DO NOT fight fire when fire reaches explosives.
P374	Fight fire with normal precautions from a reasonable distance.
P376	Stop leak if safe to do so. Oxidising gases (section 2.4) 1
P377	Leaking gas fire: Do not extinguish, unless leak can be stopped safely.
P378
P380	Evacuate area.
P381	Eliminate all ignition sources if safe to do so.
P390	Absorb spillage to prevent material damage.
P391	Collect spillage. Hazardous to the aquatic environment
P301 + P310	IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
P301 + P312	IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P301 + P330 + P331	IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P302 + P334	IF ON SKIN: Immerse in cool water/wrap in wet bandages.
P302 + P350	IF ON SKIN: Gently wash with plenty of soap and water.
P303 + P361 + P353	IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower.
P304 + P312	IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell.
P304 + P340	IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P304 + P341	IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P305 + P351 + P338	IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P306 + P360	IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes.
P307 + P311	IF exposed: call a POISON CENTER or doctor/physician.
P308 + P313	IF exposed or concerned: Get medical advice/attention.
P309 + P311	IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician.
P332 + P313	IF SKIN irritation occurs: Get medical advice/attention.
P333 + P313	IF SKIN irritation or rash occurs: Get medical advice/attention.
P335 + P334	Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages.
P337 + P313	IF eye irritation persists: Get medical advice/attention.
P342 + P311	IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician.
P370 + P376	In case of fire: Stop leak if safe to Do so.
P370 + P378	In case of fire:
P370 + P380	In case of fire: Evacuate area.
P370 + P380 + P375	In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.
P371 + P380 + P375	In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.
Storage
Code	Phrase
P401
P402	Store in a dry place.
P403	Store in a well-ventilated place.
P404	Store in a closed container.
P405	Store locked up.
P406	Store in corrosive resistant/ container with a resistant inner liner.
P407	Maintain air gap between stacks/pallets.
P410	Protect from sunlight.
P411
P412	Do not expose to temperatures exceeding 50 oC/ 122 oF.
P413
P420	Store away from other materials.
P422
P402 + P404	Store in a dry place. Store in a closed container.
P403 + P233	Store in a well-ventilated place. Keep container tightly closed.
P403 + P235	Store in a well-ventilated place. Keep cool.
P410 + P403	Protect from sunlight. Store in a well-ventilated place.
P410 + P412	Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF.
P411 + P235	Keep cool.
Disposal
Code	Phrase
P501	Dispose of contents/container to ...
P502	Refer to manufacturer/supplier for information on recovery/recycling

Ghs Hazard Statements

Physical hazards
Code	Phrase
H200	Unstable explosive
H201	Explosive; mass explosion hazard
H202	Explosive; severe projection hazard
H203	Explosive; fire, blast or projection hazard
H204	Fire or projection hazard
H205	May mass explode in fire
H220	Extremely flammable gas
H221	Flammable gas
H222	Extremely flammable aerosol
H223	Flammable aerosol
H224	Extremely flammable liquid and vapour
H225	Highly flammable liquid and vapour
H226	Flammable liquid and vapour
H227	Combustible liquid
H228	Flammable solid
H229	Pressurized container: may burst if heated
H230	May react explosively even in the absence of air
H231	May react explosively even in the absence of air at elevated pressure and/or temperature
H240	Heating may cause an explosion
H241	Heating may cause a fire or explosion
H242	Heating may cause a fire
H250	Catches fire spontaneously if exposed to air
H251	Self-heating; may catch fire
H252	Self-heating in large quantities; may catch fire
H260	In contact with water releases flammable gases which may ignite spontaneously
H261	In contact with water releases flammable gas
H270	May cause or intensify fire; oxidizer
H271	May cause fire or explosion; strong oxidizer
H272	May intensify fire; oxidizer
H280	Contains gas under pressure; may explode if heated
H281	Contains refrigerated gas; may cause cryogenic burns or injury
H290	May be corrosive to metals
Health hazards
Code	Phrase
H300	Fatal if swallowed
H301	Toxic if swallowed
H302	Harmful if swallowed
H303	May be harmful if swallowed
H304	May be fatal if swallowed and enters airways
H305	May be harmful if swallowed and enters airways
H310	Fatal in contact with skin
H311	Toxic in contact with skin
H312	Harmful in contact with skin
H313	May be harmful in contact with skin
H314	Causes severe skin burns and eye damage
H315	Causes skin irritation
H316	Causes mild skin irritation
H317	May cause an allergic skin reaction
H318	Causes serious eye damage
H319	Causes serious eye irritation
H320	Causes eye irritation
H330	Fatal if inhaled
H331	Toxic if inhaled
H332	Harmful if inhaled
H333	May be harmful if inhaled
H334	May cause allergy or asthma symptoms or breathing difficulties if inhaled
H335	May cause respiratory irritation
H336	May cause drowsiness or dizziness
H340	May cause genetic defects
H341	Suspected of causing genetic defects
H350	May cause cancer
H351	Suspected of causing cancer
H360	May damage fertility or the unborn child
H361	Suspected of damaging fertility or the unborn child
H361d	Suspected of damaging the unborn child
H362	May cause harm to breast-fed children
H370	Causes damage to organs
H371	May cause damage to organs
H372	Causes damage to organs through prolonged or repeated exposure
H373	May cause damage to organs through prolonged or repeated exposure
Environmental hazards
Code	Phrase
H400	Very toxic to aquatic life
H401	Toxic to aquatic life
H402	Harmful to aquatic life
H410	Very toxic to aquatic life with long-lasting effects
H411	Toxic to aquatic life with long-lasting effects
H412	Harmful to aquatic life with long-lasting effects
H413	May cause long-lasting harmful effects to aquatic life
H420	Harms public health and the environment by destroying ozone in the upper atmosphere

; ;